Lv31
250 积分 2023-04-18 加入
HB0025 With Chemotherapy for Advanced Non–Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial
10分钟前
求助中
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
16天前
已完结
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study
30天前
已完结
Efficacy of immune checkpoint inhibitors in the first line therapy of non-squamous non-small cell lung cancer: A systematic review and network meta-analysis
30天前
已完结
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curves
30天前
已完结
非小细胞肺癌分子病理检测临床实践指南（2026更新版）
1个月前
已完结
Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer
1个月前
已完结
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
1个月前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
1个月前
已完结
皖公网安备34019202002308
